These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
614 related articles for article (PubMed ID: 24531154)
1. Sources of extracellular tau and its signaling. Avila J; Simón D; Díaz-Hernández M; Pintor J; Hernández F J Alzheimers Dis; 2014; 40 Suppl 1():S7-S15. PubMed ID: 24531154 [TBL] [Abstract][Full Text] [Related]
2. The Neurotoxic Role of Extracellular Tau Protein. Sebastián-Serrano Á; de Diego-García L; Díaz-Hernández M Int J Mol Sci; 2018 Mar; 19(4):. PubMed ID: 29584657 [TBL] [Abstract][Full Text] [Related]
3. [Neuropathology of tauopathy]. Yoshida M Brain Nerve; 2013 Dec; 65(12):1445-58. PubMed ID: 24323931 [TBL] [Abstract][Full Text] [Related]
4. Are tangles as toxic as they look? Spires-Jones TL; Kopeikina KJ; Koffie RM; de Calignon A; Hyman BT J Mol Neurosci; 2011 Nov; 45(3):438-44. PubMed ID: 21638071 [TBL] [Abstract][Full Text] [Related]
5. From tau phosphorylation to tau aggregation: what about neuronal death? Buée L; Troquier L; Burnouf S; Belarbi K; Van der Jeugd A; Ahmed T; Fernandez-Gomez F; Caillierez R; Grosjean ME; Begard S; Barbot B; Demeyer D; Obriot H; Brion I; Buée-Scherrer V; Maurage CA; Balschun D; D'hooge R; Hamdane M; Blum D; Sergeant N Biochem Soc Trans; 2010 Aug; 38(4):967-72. PubMed ID: 20658986 [TBL] [Abstract][Full Text] [Related]
6. First-in-Rat Study of Human Alzheimer's Disease Tau Propagation. Smolek T; Jadhav S; Brezovakova V; Cubinkova V; Valachova B; Novak P; Zilka N Mol Neurobiol; 2019 Jan; 56(1):621-631. PubMed ID: 29770957 [TBL] [Abstract][Full Text] [Related]
7. Mechanisms of tau self-aggregation and neurotoxicity. Farías G; Cornejo A; Jiménez J; Guzmán L; Maccioni RB Curr Alzheimer Res; 2011 Sep; 8(6):608-14. PubMed ID: 21605046 [TBL] [Abstract][Full Text] [Related]
8. Tauopathies and tau oligomers. Takashima A J Alzheimers Dis; 2013; 37(3):565-8. PubMed ID: 23948895 [TBL] [Abstract][Full Text] [Related]
9. Hsp90 regulates tau pathology through co-chaperone complexes in Alzheimer's disease. Salminen A; Ojala J; Kaarniranta K; Hiltunen M; Soininen H Prog Neurobiol; 2011 Jan; 93(1):99-110. PubMed ID: 21056617 [TBL] [Abstract][Full Text] [Related]
10. Synthetic tau fibrils mediate transmission of neurofibrillary tangles in a transgenic mouse model of Alzheimer's-like tauopathy. Iba M; Guo JL; McBride JD; Zhang B; Trojanowski JQ; Lee VM J Neurosci; 2013 Jan; 33(3):1024-37. PubMed ID: 23325240 [TBL] [Abstract][Full Text] [Related]
11. Unique pathological tau conformers from Alzheimer's brains transmit tau pathology in nontransgenic mice. Guo JL; Narasimhan S; Changolkar L; He Z; Stieber A; Zhang B; Gathagan RJ; Iba M; McBride JD; Trojanowski JQ; Lee VM J Exp Med; 2016 Nov; 213(12):2635-2654. PubMed ID: 27810929 [TBL] [Abstract][Full Text] [Related]
12. Affinity of Tau antibodies for solubilized pathological Tau species but not their immunogen or insoluble Tau aggregates predicts in vivo and ex vivo efficacy. Congdon EE; Lin Y; Rajamohamedsait HB; Shamir DB; Krishnaswamy S; Rajamohamedsait WJ; Rasool S; Gonzalez V; Levenga J; Gu J; Hoeffer C; Sigurdsson EM Mol Neurodegener; 2016 Aug; 11(1):62. PubMed ID: 27578006 [TBL] [Abstract][Full Text] [Related]
13. Excitatory amino acid transporter 2 associates with phosphorylated tau and is localized in neurofibrillary tangles of tauopathic brains. Sasaki K; Shimura H; Itaya M; Tanaka R; Mori H; Mizuno Y; Kosik KS; Tanaka S; Hattori N FEBS Lett; 2009 Jul; 583(13):2194-200. PubMed ID: 19527721 [TBL] [Abstract][Full Text] [Related]
14. Spreading of tau pathology in Alzheimer's disease by cell-to-cell transmission. Mohamed NV; Herrou T; Plouffe V; Piperno N; Leclerc N Eur J Neurosci; 2013 Jun; 37(12):1939-48. PubMed ID: 23773063 [TBL] [Abstract][Full Text] [Related]
15. Truncated tau expression levels determine life span of a rat model of tauopathy without causing neuronal loss or correlating with terminal neurofibrillary tangle load. Koson P; Zilka N; Kovac A; Kovacech B; Korenova M; Filipcik P; Novak M Eur J Neurosci; 2008 Jul; 28(2):239-46. PubMed ID: 18702695 [TBL] [Abstract][Full Text] [Related]
16. Toxic tau aggregation in AD. Takashima A Adv Exp Med Biol; 2015; 822():3-9. PubMed ID: 25416970 [No Abstract] [Full Text] [Related]
17. Alpha1-antichymotrypsin, an inflammatory protein overexpressed in Alzheimer's disease brain, induces tau phosphorylation in neurons. Padmanabhan J; Levy M; Dickson DW; Potter H Brain; 2006 Nov; 129(Pt 11):3020-34. PubMed ID: 16987932 [TBL] [Abstract][Full Text] [Related]
18. [Neurofibrillary tangles and early modification of the neuronal cytoskeleton in Alzheimer's disease and in experimental models]. Brion JP Bull Mem Acad R Med Belg; 1999; 154(6 Pt 2):287-94. PubMed ID: 10992876 [TBL] [Abstract][Full Text] [Related]
19. Abnormal hyperphosphorylation of tau: sites, regulation, and molecular mechanism of neurofibrillary degeneration. Wang JZ; Xia YY; Grundke-Iqbal I; Iqbal K J Alzheimers Dis; 2013; 33 Suppl 1():S123-39. PubMed ID: 22710920 [TBL] [Abstract][Full Text] [Related]
20. Propagation of tau pathology: hypotheses, discoveries, and yet unresolved questions from experimental and human brain studies. Lewis J; Dickson DW Acta Neuropathol; 2016 Jan; 131(1):27-48. PubMed ID: 26576562 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]